CUEDC2: an emerging key player in inflammation and tumorigenesis.
10.1007/s13238-011-1089-z
- Author:
Jianghong MAN
1
;
Xuemin ZHANG
Author Information
1. Institute of Basic Medical Sciences, National Center of Biomedical Analysis, Beijing 100850, China.
- Publication Type:Journal Article
- MeSH:
Anaphase-Promoting Complex-Cyclosome;
Breast Neoplasms;
pathology;
Carrier Proteins;
metabolism;
Cell Cycle Proteins;
metabolism;
Cell Transformation, Neoplastic;
pathology;
Estrogen Receptor alpha;
metabolism;
Female;
Humans;
I-kappa B Kinase;
metabolism;
Inflammation;
pathology;
M Phase Cell Cycle Checkpoints;
Membrane Proteins;
metabolism;
Mitosis;
NF-kappa B p50 Subunit;
metabolism;
Receptor-Interacting Protein Serine-Threonine Kinases;
metabolism;
Signal Transduction;
Ubiquitin-Protein Ligase Complexes;
metabolism;
Ubiquitination
- From:
Protein & Cell
2011;2(9):699-703
- CountryChina
- Language:English
-
Abstract:
CUE domain-containing 2 (CUEDC2) is a protein involved in the regulation of the cell cycle, inflammation, and tumorigenesis and is highly expressed in many types of tumors. CUEDC2 is phosphorylated by Cdk1 during mitosis and promotes the release of anaphase-promoting complex or cyclosome (APC/C) from checkpoint inhibition. CUEDC2 is also known to interact with IkB kinase α (IKKα) and IKKβ and has an inhibitory role in the activation of transcription factor nuclear factor-κB. Moreover, CUEDC2 plays an important role in downregulating the expression of hormone receptors estrogen receptor-α and progesterone receptor, thereby impairing the responsiveness of breast cancer to endocrine therapies. In this review, current knowledge on the multi-functions of CUEDC2 in normal processes and tumorigenesis are discussed and summarized.
